KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,603,759 | +12.7% | 144,409 | +42.1% | 0.00% | 0.0% |
| Q2 2023 | $4,083,814 | -27.9% | 101,638 | -23.3% | 0.00% | 0.0% |
| Q1 2023 | $5,661,039 | +25.5% | 132,577 | +41.1% | 0.00% | 0.0% |
| Q4 2022 | $4,510,375 | +60.9% | 93,927 | +26.0% | 0.00% | 0.0% |
| Q3 2022 | $2,803,000 | +117.0% | 74,517 | +59.3% | 0.00% | – |
| Q2 2022 | $1,292,000 | -48.9% | 46,773 | +0.7% | 0.00% | – |
| Q1 2022 | $2,526,000 | -6.8% | 46,452 | +0.3% | 0.00% | – |
| Q4 2021 | $2,709,000 | +59.4% | 46,300 | +7.8% | 0.00% | – |
| Q3 2021 | $1,700,000 | +4.4% | 42,955 | +12.0% | 0.00% | – |
| Q2 2021 | $1,629,000 | -38.1% | 38,360 | -10.2% | 0.00% | -100.0% |
| Q1 2021 | $2,630,000 | -13.0% | 42,729 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $3,022,000 | +332.3% | 42,853 | +136.7% | 0.00% | – |
| Q3 2020 | $699,000 | +2.5% | 18,105 | -0.5% | 0.00% | – |
| Q2 2020 | $682,000 | – | 18,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |